330 related articles for article (PubMed ID: 26998835)
1. Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt/β-catenin defects in neuronal cholesterol synthesis phenotypes.
Francis KR; Ton AN; Xin Y; O'Halloran PE; Wassif CA; Malik N; Williams IM; Cluzeau CV; Trivedi NS; Pavan WJ; Cho W; Westphal H; Porter FD
Nat Med; 2016 Apr; 22(4):388-96. PubMed ID: 26998835
[TBL] [Abstract][Full Text] [Related]
2. Residual cholesterol synthesis and simvastatin induction of cholesterol synthesis in Smith-Lemli-Opitz syndrome fibroblasts.
Wassif CA; Krakowiak PA; Wright BS; Gewandter JS; Sterner AL; Javitt N; Yergey AL; Porter FD
Mol Genet Metab; 2005 Jun; 85(2):96-107. PubMed ID: 15896653
[TBL] [Abstract][Full Text] [Related]
3. Discordant phenotype and sterol biochemistry in Smith-Lemli-Opitz syndrome.
Koo G; Conley SK; Wassif CA; Porter FD
Am J Med Genet A; 2010 Aug; 152A(8):2094-8. PubMed ID: 20635399
[TBL] [Abstract][Full Text] [Related]
4. Reduced cholesterol levels impair Smoothened activation in Smith-Lemli-Opitz syndrome.
Blassberg R; Macrae JI; Briscoe J; Jacob J
Hum Mol Genet; 2016 Feb; 25(4):693-705. PubMed ID: 26685159
[TBL] [Abstract][Full Text] [Related]
5. Aripiprazole and trazodone cause elevations of 7-dehydrocholesterol in the absence of Smith-Lemli-Opitz Syndrome.
Hall P; Michels V; Gavrilov D; Matern D; Oglesbee D; Raymond K; Rinaldo P; Tortorelli S
Mol Genet Metab; 2013; 110(1-2):176-8. PubMed ID: 23628460
[TBL] [Abstract][Full Text] [Related]
6. Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management.
Porter FD
Eur J Hum Genet; 2008 May; 16(5):535-41. PubMed ID: 18285838
[TBL] [Abstract][Full Text] [Related]
7. Recent insights into the Smith-Lemli-Opitz syndrome.
Yu H; Patel SB
Clin Genet; 2005 Nov; 68(5):383-91. PubMed ID: 16207203
[TBL] [Abstract][Full Text] [Related]
8. Quantitative proteomics analysis of inborn errors of cholesterol synthesis: identification of altered metabolic pathways in DHCR7 and SC5D deficiency.
Jiang XS; Backlund PS; Wassif CA; Yergey AL; Porter FD
Mol Cell Proteomics; 2010 Jul; 9(7):1461-75. PubMed ID: 20305089
[TBL] [Abstract][Full Text] [Related]
9. Lowered DHCR7 activity measured by ergosterol conversion in multiple cell types in Smith-Lemli-Opitz syndrome.
Ginat S; Battaile KP; Battaile BC; Maslen C; Gibson KM; Steiner RD
Mol Genet Metab; 2004; 83(1-2):175-83. PubMed ID: 15464432
[TBL] [Abstract][Full Text] [Related]
10. Mutational spectrum of Smith-Lemli-Opitz syndrome.
Waterham HR; Hennekam RC
Am J Med Genet C Semin Med Genet; 2012 Nov; 160C(4):263-84. PubMed ID: 23042628
[TBL] [Abstract][Full Text] [Related]
11. Compromised phagosome maturation underlies RPE pathology in cell culture and whole animal models of Smith-Lemli-Opitz Syndrome.
Ramachandra Rao S; Pfeffer BA; Más Gómez N; Skelton LA; Keiko U; Sparrow JR; Rowsam AM; Mitchell CH; Fliesler SJ
Autophagy; 2018; 14(10):1796-1817. PubMed ID: 29979914
[TBL] [Abstract][Full Text] [Related]
12. Abnormal cholesterol biosynthesis as in Smith-Lemli-Opitz syndrome disrupts normal skeletal development in the rat.
Kolf-Clauw M; Chevy F; Ponsart C
J Lab Clin Med; 1998 Mar; 131(3):222-7. PubMed ID: 9523845
[TBL] [Abstract][Full Text] [Related]
13. Prenatal diagnosis of Smith-Lemli-Opitz syndrome (SLOS) by DHCR7 mutation analysis.
Waye JS; Eng B; Nowaczyk MJ
Prenat Diagn; 2007 Jul; 27(7):638-40. PubMed ID: 17441222
[TBL] [Abstract][Full Text] [Related]
14. Smith-Lemli-Opitz syndrome: phenotype, natural history, and epidemiology.
Nowaczyk MJ; Irons MB
Am J Med Genet C Semin Med Genet; 2012 Nov; 160C(4):250-62. PubMed ID: 23059950
[TBL] [Abstract][Full Text] [Related]
15. 7-Dehydrocholesterol-derived oxysterols cause neurogenic defects in Smith-Lemli-Opitz syndrome.
Tomita H; Hines KM; Herron JM; Li A; Baggett DW; Xu L
Elife; 2022 Sep; 11():. PubMed ID: 36111785
[TBL] [Abstract][Full Text] [Related]
16. Identification of nine novel DHCR7 missense mutations in patients with Smith-Lemli-Opitz syndrome (SLOS).
Waye JS; Krakowiak PA; Wassif CA; Sterner AL; Eng B; Nakamura LM; Nowaczyk MJ; Porter FD
Hum Mutat; 2005 Jul; 26(1):59. PubMed ID: 15954111
[TBL] [Abstract][Full Text] [Related]
17. 7-dehydrocholesterol efficiently supports Ret signaling in a mouse model of Smith-Opitz-Lemli syndrome.
Gou-Fàbregas M; Macià A; Anerillas C; Vaquero M; Jové M; Jain S; Ribera J; Encinas M
Sci Rep; 2016 Jun; 6():28534. PubMed ID: 27334845
[TBL] [Abstract][Full Text] [Related]
18. Maternal urinary steroid profiles in prenatal diagnosis of Smith-Lemli-Opitz syndrome: first patient series comparing biochemical and molecular studies.
Jezela-Stanek A; Małunowicz EM; Ciara E; Popowska E; Goryluk-Kozakiewicz B; Spodar K; Czerwiecka M; Jezuita J; Nowaczyk MJ; Krajewska-Walasek M
Clin Genet; 2006 Jan; 69(1):77-85. PubMed ID: 16451140
[TBL] [Abstract][Full Text] [Related]
19. Smith-Lemli-Opitz syndrome.
DeBarber AE; Eroglu Y; Merkens LS; Pappu AS; Steiner RD
Expert Rev Mol Med; 2011 Jul; 13():e24. PubMed ID: 21777499
[TBL] [Abstract][Full Text] [Related]
20. 3beta-hydroxysterol Delta7-reductase and the Smith-Lemli-Opitz syndrome.
Correa-Cerro LS; Porter FD
Mol Genet Metab; 2005 Feb; 84(2):112-26. PubMed ID: 15670717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
